New pill aims to stop leukemia from coming back after transplant
NCT ID NCT03932643
Summary
This early-stage study tested whether a weekly pill called ONC-201 could safely help prevent leukemia or MDS from returning after a stem cell transplant. It involved 20 patients who had recently received a transplant and took the pill for up to one year. The main goal was to check for side effects and see if the treatment showed early signs of keeping the cancer away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.